Cancer advocates and leading members of the medical community across the nation are voicing their appreciation for U.S. Senator Katie Britt’s staunch leadership and support of federal research funding.

Britt (R-Montgomery) has been the tip of the spear in the fight to responsibly reform NIH’s spending while strengthening investments in critical medical research and innovation at places like the University of Alabama at Birmingham, the University of South Alabama, and HudsonAlpha Institute for Biotechnology.

RELATED: Britt’s advocacy leads to RFK praising UAB for ‘cutting-edge research’

Recently, Senator Britt led a letter joined by several of her Senate Republican colleagues advocating for the disbursement of appropriated funds for NIH in order to advance President Trump’s goals of curing diseases and making America healthy again.

Specifically, the letter requests that the administration implement the Fiscal Year 2025 continuing resolution, which President Trump signed into law earlier this year.

“The continuing resolution supports NIH initiatives across a range of critical research areas—cancer, cardiovascular disease, rare pediatric disorders, and more.  These vital efforts are not only necessary to Make America Healthy Again, but also have a direct impact on American families, biomedical innovation, our economy, and competing with Communist China,” Britt’s letter said.

“We share your commitment to ensuring NIH funds are used responsibly and not diverted to ideological or unaccountable programs,” the Senators added.

“We are confident Secretary Kennedy and Director Bhattacharya are well positioned to uphold gold standard research by ensuring that NIH awards are grounded in transparency, scientific merit, and a clear alignment with national interests. Our shared goal is to restore public trust in the NIH precisely because its work is focused on results, accountability, and real-world impact. Withholding or suspending these funds would jeopardize that trust and hinder progress on critical health challenges facing our nation. Ultimately, this is about finding cures and seeing them through to fruition.”

RELATED: After counsel from Katie Britt, President Trump takes most pro-IVF action in federal history

Britt’s strong stance has drawn praise from across Alabama as well as the nation.

A spokesperson from UAB wrote that the University appreciated Britt’s “continued efforts to support critical NIH funding that improves and saves lives.”

The American Association for Cancer Research (AACR), Association of American Cancer Institutes, and United for Medical Research are among the organizations that released statements commending Britt for her leadership.

AACR wrote that Britt’s letter “is a powerful reaffirmation that medical research must remain a national priority, rooted in bipartisan support, scientific excellence, and the urgent needs of patients and families. It also comes at a time of growing concern about the stability of the NIH funding process.”

On Thursday, Britt – as a member of the Senate Appropriations Committee and the subcommittee that funds Health and Human Services – voted to advance a $400 million annual increase in NIH funding, including a $150 million increase for the National Cancer Institute and a $20 million increase for the NIH Improve Initiative.

Britt has been a leading champion of this bipartisan maternal health research program.